Medicure Inc.
MCUJF
$0.50
$0.0051.01%
| Weiss Ratings | MCUJF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | D | |||
| Rating Factors | MCUJF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | MCUJF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.40 | |||
| Price History | MCUJF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.01% | |||
| 30-Day Total Return | -6.02% | |||
| 60-Day Total Return | -28.57% | |||
| 90-Day Total Return | -20.64% | |||
| Year to Date Total Return | -15.97% | |||
| 1-Year Total Return | -36.65% | |||
| 2-Year Total Return | -35.58% | |||
| 3-Year Total Return | -38.19% | |||
| 5-Year Total Return | -62.96% | |||
| 52-Week High % Change | -45.65% | |||
| 52-Week Low % Change | 5.26% | |||
| Price | MCUJF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.92 | |||
| 52-Week Low Price | $0.48 | |||
| 52-Week Low Price (Date) | Mar 04, 2025 | |||
| 52-Week High Price (Date) | Jul 01, 2024 | |||
| Valuation | MCUJF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 6.46M | |||
| Enterprise Value | 3.70M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.15 | |||
| Earnings Per Share Growth | -302.09% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.34 | |||
| Price/Book (Q) | 0.35 | |||
| Enterprise Value/Revenue (TTM) | 0.24 | |||
| Price | $0.50 | |||
| Enterprise Value/EBITDA (TTM) | -2.18 | |||
| Enterprise Value/EBIT | -1.22 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | MCUJF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 10.44M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MCUJF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 204 487 7412 | |||
| Address | 2-1250 Waverley Street Winnipeg, MB R3T 6C6 | |||
| Website | www.medicure.com | |||
| Country | Canada | |||
| Year Founded | 1997 | |||
| Profitability | MCUJF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -19.47% | |||
| Profit Margin | -9.61% | |||
| Management Effectiveness | MCUJF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -8.90% | |||
| Return on Equity | -- | |||
| Income Statement | MCUJF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 15.50M | |||
| Total Revenue (TTM) | 15.50M | |||
| Revenue Per Share | $1.49 | |||
| Gross Profit (TTM) | 8.63M | |||
| EBITDA (TTM) | -1.69M | |||
| EBIT (TTM) | -3.02M | |||
| Net Income (TTM) | -1.49M | |||
| Net Income Avl. to Common (TTM) | -1.49M | |||
| Total Revenue Growth (Q YOY) | 1.31% | |||
| Earnings Growth (Q YOY) | 696.49% | |||
| EPS Diluted (TTM) | -0.15 | |||
| EPS Diluted Growth (Q YOY) | 696.67% | |||
| Balance Sheet | MCUJF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.62M | |||
| Cash Per Share (Q) | $0.35 | |||
| Total Current Assets (Q) | 11.95M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 14.79M | |||
| Current Ratio (Q) | 2.030 | |||
| Book Value Per Share (Q) | $1.42 | |||
| Total Assets (Q) | 21.09M | |||
| Total Current Liabilities (Q) | 5.89M | |||
| Total Debt (Q) | 688.40K | |||
| Total Liabilities (Q) | 6.30M | |||
| Total Common Equity (Q) | 14.79M | |||
| Cash Flow | MCUJF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -307.90K | |||
| Cash from Financing (TTM) | -236.70K | |||
| Net Change in Cash (TTM) | -547.60K | |||
| Levered Free Cash Flow (TTM) | -671.20K | |||
| Cash from Operations (TTM) | -3.00K | |||
